Sanofi Considers Taking Over Insmed, Bloomberg Reports
· Business · Reuters, Bloomberg
Sanofi is evaluating a takeover of US-based drugmaker Insmed, according to Bloomberg News. The potential deal involves a significant premium to Insmed's current market value, though specific terms and timing remain undisclosed. Insmed focuses on developing therapies for rare diseases and has been exploring strategic options. No formal offer has been made, and the discussions may not lead to a transaction. The move would mark Sanofi's largest acquisition in years as it seeks growth in specialty medicines.
Why it matters
The potential deal could reshape the specialty pharmaceutical landscape and impact access to rare disease treatments in the US and globally.
Read the original report — Reuters
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.